超声引导射频消融:慢性肾脏病继发性难治性甲状旁腺功能亢进治疗的新尝试
回顾性比较射频消融(RFA)与甲状旁腺切除加自体移植(PTX+AT)治疗慢性肾脏病继发性难治性甲状旁腺功能亢进的80例患者,两组术后甲状旁腺激素、钙、磷及视觉模拟评分均显著改善,PTX+AT术后早期甲状旁腺激素及第1天钙磷下降更明显,RFA组严重低钙血症发生率更低且住院时间更短,6个月复发率两组无显著差异。
要点
- RFA与PTX+AT均可显著改善难治性SHPT患者的甲状旁腺激素、钙、磷及VAS评分。
- RFA组严重低钙血症发生率20%低于PTX+AT组46.67%,住院时间更短。
- 两组6个月复发率23.3%与30%无显著差异,喉返神经损伤发生率无显著差异。
核心结论
- RFA可治疗难治性继发性甲状旁腺功能亢进,临床疗效与手术相似,且恢复更快、术后严重低钙血症发生率更低。
研究设计与样本
- 回顾性研究纳入2018年1月至2021年2月期间接受RFA或PTX+AT治疗的80例慢性肾脏病继发性难治性甲状旁腺功能亢进患者,比较两组血清甲状旁腺激素、钙、磷水平、并发症、临床症状、视觉模拟评分、住院时间和术后复发率。
主要发现
- RFA和PTX+AT术后血清甲状旁腺激素、磷、钙水平及视觉模拟评分均显著改善(P < 0.05)。
- 两组术后第1天和第1周血清甲状旁腺激素水平及术后第1天血清钙、磷水平差异显著(P < 0.05),PTX+AT组下降更明显。
- RFA组喉返神经损伤发生率为26.67%,PTX+AT组为16.67%(P > 0.05)。
- RFA组严重低钙血症发生率为20%,PTX+AT组为46.67%(P < 0.05);RFA组住院时间为7.53 ± 2.67天,PTX+AT组为12.13 ± 3.86天(P < 0.05)。
- RFA组6个月复发率为23.3%(7/30),PTX+AT组为30%(9/30)(P > 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: To evaluate clinical application value of radiofrequency ablation (RFA) in refractory hyperparathyroidism secondary to chronic kidney disease (CKD) by comparing the safety and effectiveness of RFA with parathyroidectomy with autotransplantation (PTX + AT). METHODS: A retrospective study was conducted on 80 patients with CKD with refractory hyperparathyroidism who underwent RFA or PTX + AT between January 2018 and February 2021. Serum parathyroid hormone (PTH), calcium, and phosphorus levels, complications, clinical symptoms, visual analogue scale (VAS) scores, hospital stay duration, and postoperative recurrence rate were compared between the 2 groups. RESULTS: Serum PTH, phosphorous, and calcium levels and the VAS scores improved significantly after RFA and PTX + AT (P < 0.05). Significant differences were observed between the 2 groups in postoperative (day 1 and week 1) levels of serum PTH and postoperative day 1 of serum calcium and phosphorus levels (P < 0.05), with more pronounced reduction after PTX + AT. Although the incidence of recurrent laryngeal nerve (RLN) injury was slightly higher in the RFA group compared with the PTX + AT group (26.67% vs. 16.67%; P > 0.05), RFA markedly decreased the risk of severe hypocalcemia (SH) (20% vs. 46.67%; P < 0.05) and shortened hospital stay (7.53 ± 2.67 days vs. 12.13 ± 3.86 days; P < 0.05). The 6-month recurrence rate was 23.3% (7 of 30) in the RFA group and 30% (9 of 30) in the PTX + AT group (P > 0.05). CONCLUSION: RFA can treat refractory secondary hyperparathyroidism (SHPT) with similar clinical efficacy as surgery and achieve faster recovery and a lower incidence of postoperative SH.
引用
- Zhang DL, Chen S, Gao MZ, et al. Ultrasound-Guided Radiofrequency Ablation: A New Attempt to the Treatment of Refractory Hyperparathyroidism Secondary to Chronic Kidney Disease. Kidney Int Rep. 2021. PMID: 35155867. doi:10.1016/j.ekir.2021.11.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。